BSD Medical Corp (NASDAQ:BSDM)

CAPS Rating: 1 out of 5

The Company develops, manufactures, markets and services medical systems that deliver precision-focused radio frequency or microwave energy into diseased sites of the body, heating them to specified temperatures as required by medical therapies.

Results 1 - 20 of 31 : 1 2 Next »

Recs

0
Member Avatar SnarkyApple (40.08) Submitted: 12/7/2012 12:02:14 PM : Outperform Start Price: $1.69 BSDM Score: -89.39

Upcoming pump and dump.

Recs

0
Member Avatar 1Sonofnike (< 20) Submitted: 11/6/2012 10:12:04 AM : Outperform Start Price: $1.97 BSDM Score: -95.55

The most advanced and sofisticated technology available. When the market will understand this breaktrought technique the stock will move in the 30s very quicly.

Recs

0
Member Avatar markz13 (< 20) Submitted: 5/21/2011 3:31:11 PM : Outperform Start Price: $3.60 BSDM Score: -124.39

With the hiring of their sales team..BSD should have a very good 2011..

Recs

0
Member Avatar PSUPETE84 (< 20) Submitted: 4/1/2011 1:18:21 PM : Outperform Start Price: $4.41 BSDM Score: -126.78

New technology is very promising.

Recs

0
Member Avatar rolman80 (< 20) Submitted: 12/10/2010 5:21:06 PM : Outperform Start Price: $4.03 BSDM Score: -134.83

As the population ages the need for cancer treatment will increase. From what I have researched ,this technology coupled with chemo, or radiation has a big impact on the destruction of cancer cells and increasing longivity of the patient.

Recs

0
Member Avatar hoperalot1 (< 20) Submitted: 11/16/2010 4:25:00 PM : Outperform Start Price: $6.34 BSDM Score: -150.90

Excellent potential----Great need for product--this one will move up to at least 10+

Recs

0
Member Avatar westcor1 (< 20) Submitted: 10/20/2010 10:50:43 AM : Outperform Start Price: $3.60 BSDM Score: -142.02

An Intuitive surgical style rocket shot or a fizzle on the launch pad? The recent approval of the MX180 and the patent on the applicators creates a near term blockbuster opportunity. Unlike thier million dollar machines the MX180 will sell for around 30 thousand. The high margin patented applicators for around 15 hundred each with up to 3 applicators used per treatment. The high margin revenue per device will likely average a million dollars per year times just 50 to 100 equipment placements and they have a an extremely profitable company with the enhanced opportunity for increased sales of their more costly hyperthermia medical devices. The big ticket devices already deliver the desired results and hold the future promise of helping to eradicate tumors while using smaller, safer doses of chemo. BSDM owns their certified production facility, have zero debt and ample cash. They are currently working on a major sales distribution agreement to accelerate the placements of their equipment. In a toxic world with an aging population I believe they are poised for enormous sales growth and profits.

Recs

0
Member Avatar carl9186 (< 20) Submitted: 9/5/2010 9:09:48 PM : Outperform Start Price: $2.27 BSDM Score: -140.19

It will expand business in China very quickly

Recs

0
Member Avatar sholabern (< 20) Submitted: 9/2/2010 10:20:40 AM : Outperform Start Price: $2.24 BSDM Score: -142.09

This stock just recently received approval from FDA to market their product

Recs

0
Member Avatar benadum (50.84) Submitted: 6/14/2010 11:54:31 AM : Outperform Start Price: $1.37 BSDM Score: -116.51

Should have FDA approval on new unit within the next 30 days.

Recs

0
Member Avatar enilesh (< 20) Submitted: 11/4/2008 3:39:54 PM : Outperform Start Price: $5.09 BSDM Score: -181.30

Good growth story for the long term. This stock can double in year or so.

Recs

0
Member Avatar paulmacdo (< 20) Submitted: 7/9/2008 3:22:29 PM : Outperform Start Price: $5.71 BSDM Score: -144.91

FDA approval on BSD-2000 and sales ramping combine for some major upside potential.

Recs

0
Member Avatar nickelndiamond (48.60) Submitted: 3/6/2008 8:10:40 AM : Outperform Start Price: $5.09 BSDM Score: -135.82

This stock has great potential for growth but this is not a stock for the short term investor. Promising treatments could revolutionize medical treatments for many therapies but it is a waiting game with the FDA.

Recs

0
Member Avatar bjkrush (< 20) Submitted: 2/29/2008 5:21:02 PM : Outperform Start Price: $5.31 BSDM Score: -136.28

FDA approval anytime, M100 FDA submittal in March.

Recs

0
Member Avatar smoovius (90.13) Submitted: 1/8/2008 4:19:36 AM : Outperform Start Price: $4.70 BSDM Score: -124.85

Promising technology STILL awaiting the same approval referenced on here in comment from April 07... BSD just received response from FDA specifying what needs to be done for application approval at this point... This is very promising, as the FDA offering its guidance suggests that only minor issues exist and further delays are hopefully insignificant.

The worst should be behind us here on this news, and price should settle and recover. Should prove to be an excellent entry point in the longterm, though it may take awhile to get back on track.

Recs

0
Member Avatar OGT07 (< 20) Submitted: 6/4/2007 10:47:40 AM : Outperform Start Price: $8.53 BSDM Score: -123.47



excellent cancer solution that betters the mortality rate when used in concert with radiation... cancer treatment center of america will increase market awareness

Recs

2
Member Avatar vcbthornton (74.37) Submitted: 5/10/2007 12:08:29 PM : Underperform Start Price: $7.01 BSDM Score: +124.92

I checked, and I can't fault Fool Rich Duprey's April 25 article on BSM. No profits for 10 years, a cancer treatment of questionable value, the bulk of sales to a member of the board of directors. The SEC 10-Q is singularly uninformative. A lot of people seem to like BSM, but I can't see why.

Recs

0
Member Avatar Mactalon (97.71) Submitted: 5/3/2007 12:13:08 PM : Underperform Start Price: $7.45 BSDM Score: +125.42

Current return on assets is -13%... whether that is because of bad management or just that the products haven't hit the springboard yet is hard to tell. Also, their net income has consistently been under the water for the past three quarters.

It has its bright spots, but IMHO, its not a shining star.

Recs

1
Member Avatar addnauseeum (83.05) Submitted: 4/20/2007 3:29:31 PM : Outperform Start Price: $7.38 BSDM Score: -127.15

FDA approval on the 2000 should drive the price up substantially. Said approval seems very likely at this point. But this issue is definitely speculative.

Recs

0
Member Avatar lostbear10 (26.22) Submitted: 4/16/2007 3:49:25 PM : Outperform Start Price: $7.90 BSDM Score: -129.17

Hot, HOT, HOT! No pun intended.

Put some mad money into this stock and smile when it goes up. I would sell at $10-11 range and buy again on dips.

Watch the news closely on this one.

Results 1 - 20 of 31 : 1 2 Next »

Featured Broker Partners


Advertisement